guest ::
| Home > Publications Database > The Role of Tau Imaging in Parkinsonian Disorders. > print |
| 001 | 140256 | ||
| 005 | 20240321220756.0 | ||
| 024 | 7 | _ | |a 10.1007/s11910-018-0898-3 |2 doi |
| 024 | 7 | _ | |a pmid:30293094 |2 pmid |
| 024 | 7 | _ | |a 1528-4042 |2 ISSN |
| 024 | 7 | _ | |a 1534-6293 |2 ISSN |
| 024 | 7 | _ | |a altmetric:49470336 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-06578 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Hammes, Jochen |0 P:(DE-HGF)0 |b 0 |e Corresponding author |
| 245 | _ | _ | |a The Role of Tau Imaging in Parkinsonian Disorders. |
| 260 | _ | _ | |a Philadelphia, Pa. |c 2018 |b Current Science Inc. |
| 264 | _ | 1 | |3 online |2 Crossref |b Springer Science and Business Media LLC |c 2018-10-06 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2018-12-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1588840567_23250 |2 PUB:(DE-HGF) |x Review Article |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Differential diagnosis of atypical Parkinson syndromes (APS) is difficult as clinical presentations may vary and as there is a strong overlap between disease entities. Aggregations of misfolded and hyperphosphorylated tau proteins are the common denominator of many of these diseases.Several tau targeting positron emission tomography (PET) tracers have been evaluated as possible biomarkers in APS in the recent years. For Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy, and corticobasal degeneration, promising results have been reported with regard to the ability to detect the presence of disease and to discriminate patients from controls. However, the discussion about the specificity of the first-generation radiotracers and their value in the clinical context is ongoing. A combined interpretation of signal strength and distribution pattern in PET scans with first- and second-generation tracers may be helpful in clinical diagnosis and follow-up of patients with APS. |
| 536 | _ | _ | |a 344 - Clinical and Health Care Research (POF3-344) |0 G:(DE-HGF)POF3-344 |c POF3-344 |f POF III |x 0 |
| 542 | _ | _ | |i 2018-10-06 |2 Crossref |u http://www.springer.com/tdm |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a tau Proteins |2 NLM Chemicals |
| 650 | _ | 2 | |a Alzheimer Disease: diagnosis |2 MeSH |
| 650 | _ | 2 | |a Alzheimer Disease: diagnostic imaging |2 MeSH |
| 650 | _ | 2 | |a Alzheimer Disease: metabolism |2 MeSH |
| 650 | _ | 2 | |a Diagnosis, Differential |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Parkinsonian Disorders: diagnostic imaging |2 MeSH |
| 650 | _ | 2 | |a Parkinsonian Disorders: metabolism |2 MeSH |
| 650 | _ | 2 | |a Positron-Emission Tomography: methods |2 MeSH |
| 650 | _ | 2 | |a Supranuclear Palsy, Progressive: diagnosis |2 MeSH |
| 650 | _ | 2 | |a Supranuclear Palsy, Progressive: diagnostic imaging |2 MeSH |
| 650 | _ | 2 | |a Supranuclear Palsy, Progressive: metabolism |2 MeSH |
| 650 | _ | 2 | |a tau Proteins: metabolism |2 MeSH |
| 700 | 1 | _ | |a Drzezga, Alexander |0 P:(DE-2719)2811239 |b 1 |u dzne |
| 700 | 1 | _ | |a Eimeren, Thilo |0 P:(DE-2719)2812285 |b 2 |e Last author |u dzne |
| 773 | 1 | 8 | |a 10.1007/s11910-018-0898-3 |b : Springer Science and Business Media LLC, 2018-10-06 |n 12 |p 86 |3 journal-article |2 Crossref |t Current Neurology and Neuroscience Reports |v 18 |y 2018 |x 1528-4042 |
| 773 | _ | _ | |a 10.1007/s11910-018-0898-3 |g Vol. 18, no. 12, p. 86 |0 PERI:(DE-600)2094171-7 |n 12 |q 18:12<86 |p 86 |t Current neurology and neuroscience reports |v 18 |y 2018 |x 1528-4042 |
| 909 | C | O | |o oai:pub.dzne.de:140256 |p VDB |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2811239 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2812285 |
| 913 | 1 | _ | |a DE-HGF |b Forschungsbereich Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-344 |2 G:(DE-HGF)POF3-300 |v Clinical and Health Care Research |x 0 |
| 914 | 1 | _ | |y 2018 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-12 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-12 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CURR NEUROL NEUROSCI : 2021 |d 2022-11-12 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CURR NEUROL NEUROSCI : 2021 |d 2022-11-12 |
| 920 | 1 | _ | |0 I:(DE-2719)1011202 |k AG Boecker |l Positron Emissions Tomography (PET) |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1011101 |k Patient studies, Bonn |l Patient studies |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1011202 |
| 980 | _ | _ | |a I:(DE-2719)1011101 |
| 980 | _ | _ | |a UNRESTRICTED |
| 999 | C | 5 | |a 10.1016/j.parkreldis.2017.07.031 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.parkreldis.2017.07.031 |
| 999 | C | 5 | |a 10.1007/s00401-013-1230-6 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00401-013-1230-6 |
| 999 | C | 5 | |a 10.1016/j.ymeth.2017.08.003 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.ymeth.2017.08.003 |
| 999 | C | 5 | |a 10.2967/jnumed.117.190082 |9 -- missing cx lookup -- |2 Crossref |o 10.2967/jnumed.117.190082 |
| 999 | C | 5 | |a 10.1007/s40336-017-0242-y |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s40336-017-0242-y |
| 999 | C | 5 | |a 10.1016/S1474-4422(05)70285-4 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S1474-4422(05)70285-4 |
| 999 | C | 5 | |a 10.1002/mds.26987 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.26987 |
| 999 | C | 5 | |a 10.1016/S1474-4422(09)70042-0 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/S1474-4422(09)70042-0 |
| 999 | C | 5 | |y 2016 |2 Crossref |o NR McFarland 2016 |
| 999 | C | 5 | |a 10.1007/s40263-016-0347-2 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s40263-016-0347-2 |
| 999 | C | 5 | |a 10.1080/13543784.2018.1460356 |9 -- missing cx lookup -- |2 Crossref |o 10.1080/13543784.2018.1460356 |
| 999 | C | 5 | |a 10.1016/j.neuron.2013.10.009 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.neuron.2013.10.009 |
| 999 | C | 5 | |a 10.1016/j.neuron.2013.07.046 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.neuron.2013.07.046 |
| 999 | C | 5 | |a 10.1007/s13139-017-0484-7 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s13139-017-0484-7 |
| 999 | C | 5 | |a 10.1038/nrneurol.2018.9 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nrneurol.2018.9 |
| 999 | C | 5 | |a 10.2967/jnumed.117.196741 |9 -- missing cx lookup -- |2 Crossref |o 10.2967/jnumed.117.196741 |
| 999 | C | 5 | |a 10.2174/1567205013666160620121811 |9 -- missing cx lookup -- |2 Crossref |o 10.2174/1567205013666160620121811 |
| 999 | C | 5 | |a 10.2967/jnumed.116.185199 |9 -- missing cx lookup -- |2 Crossref |o 10.2967/jnumed.116.185199 |
| 999 | C | 5 | |a 10.1002/mds.27034 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.27034 |
| 999 | C | 5 | |a 10.1111/nan.12208 |9 -- missing cx lookup -- |2 Crossref |o 10.1111/nan.12208 |
| 999 | C | 5 | |a 10.1002/ana.24844 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/ana.24844 |
| 999 | C | 5 | |a 10.1002/mds.26813 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.26813 |
| 999 | C | 5 | |a 10.3389/fnagi.2017.00440 |9 -- missing cx lookup -- |2 Crossref |o 10.3389/fnagi.2017.00440 |
| 999 | C | 5 | |a 10.1093/brain/awx347 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/brain/awx347 |
| 999 | C | 5 | |a 10.1002/ana.25060 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/ana.25060 |
| 999 | C | 5 | |a 10.1002/mds.27029 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.27029 |
| 999 | C | 5 | |a 10.1002/mds.26844 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.26844 |
| 999 | C | 5 | |a 10.1111/ene.13164 |9 -- missing cx lookup -- |2 Crossref |o 10.1111/ene.13164 |
| 999 | C | 5 | |a 10.1002/mds.26727 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.26727 |
| 999 | C | 5 | |a 10.1007/s00429-017-1507-y |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00429-017-1507-y |
| 999 | C | 5 | |a 10.1002/mds.26834 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.26834 |
| 999 | C | 5 | |a 10.1093/brain/awm104 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/brain/awm104 |
| 999 | C | 5 | |a 10.1212/WNL.0000000000004264 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/WNL.0000000000004264 |
| 999 | C | 5 | |a 10.1212/WNL.0000000000003375 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/WNL.0000000000003375 |
| 999 | C | 5 | |a 10.1007/s00401-016-1618-1 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00401-016-1618-1 |
| 999 | C | 5 | |a 10.1007/s00401-016-1640-3 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00401-016-1640-3 |
| 999 | C | 5 | |a 10.1186/alzrt240 |9 -- missing cx lookup -- |2 Crossref |o 10.1186/alzrt240 |
| 999 | C | 5 | |a 10.1212/WNL.0000000000005069 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/WNL.0000000000005069 |
| 999 | C | 5 | |a 10.1212/WNL.0000000000004364 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/WNL.0000000000004364 |
| 999 | C | 5 | |a 10.1093/brain/aww098 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/brain/aww098 |
| 999 | C | 5 | |a 10.3389/fneur.2018.00123 |9 -- missing cx lookup -- |2 Crossref |o 10.3389/fneur.2018.00123 |
| 999 | C | 5 | |a 10.1186/s12916-018-1016-8 |9 -- missing cx lookup -- |2 Crossref |o 10.1186/s12916-018-1016-8 |
| 999 | C | 5 | |a 10.1038/nrn3549 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nrn3549 |
| 999 | C | 5 | |a 10.1001/jamaneurol.2016.3338 |9 -- missing cx lookup -- |2 Crossref |o 10.1001/jamaneurol.2016.3338 |
| 999 | C | 5 | |a 10.1002/mds.27252 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.27252 |
| 999 | C | 5 | |a 10.1002/ana.24825 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/ana.24825 |
| 999 | C | 5 | |a 10.1056/NEJMra1311488 |9 -- missing cx lookup -- |2 Crossref |o 10.1056/NEJMra1311488 |
| 999 | C | 5 | |a 10.1007/s00401-005-0022-z |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00401-005-0022-z |
| 999 | C | 5 | |a 10.1111/j.1440-1789.2010.01159.x |9 -- missing cx lookup -- |2 Crossref |o 10.1111/j.1440-1789.2010.01159.x |
| 999 | C | 5 | |a 10.1111/j.1440-1789.2011.01246.x |9 -- missing cx lookup -- |2 Crossref |o 10.1111/j.1440-1789.2011.01246.x |
| 999 | C | 5 | |a 10.1002/mds.26857 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.26857 |
| 999 | C | 5 | |y 2017 |2 Crossref |o DW Wooten 2017 |
| 999 | C | 5 | |y 2016 |2 Crossref |o S Shcherbinin 2016 |
| 999 | C | 5 | |a 10.1002/mds.22108 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.22108 |
| 999 | C | 5 | |y 2017 |2 Crossref |o A Siderowf 2017 |
| 999 | C | 5 | |a 10.1186/s40478-018-0535-z |9 -- missing cx lookup -- |2 Crossref |o 10.1186/s40478-018-0535-z |
| 999 | C | 5 | |a 10.1186/s13195-017-0253-y |9 -- missing cx lookup -- |2 Crossref |o 10.1186/s13195-017-0253-y |
| 999 | C | 5 | |a 10.1016/j.jalz.2012.11.008 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.jalz.2012.11.008 |
| 999 | C | 5 | |a 10.1002/mds.27271 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/mds.27271 |
| 999 | C | 5 | |a 10.1007/s11307-017-1143-1 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s11307-017-1143-1 |
| 999 | C | 5 | |a 10.1007/s00259-017-3840-z |9 -- missing cx lookup -- |2 Crossref |o 10.1007/s00259-017-3840-z |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|